Next Financial Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Next Financial Group’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Hold	129	–	–	﹤0.01%	2827
2021 Q3	$4K	Hold	129	–	–	﹤0.01%	2345
2021 Q2	$6K	Sell	129 -55	-30%	-$2.26K	﹤0.01%	2173
2021 Q1	$9K	Hold	184	–	–	﹤0.01%	1933
2020 Q4	$6K	Hold	184	–	–	﹤0.01%	1953
2020 Q3	$7K	Buy	+184	New	+$7.24K	﹤0.01%	1758
2020 Q2	–	Sell	-184	Closed	-$10K	–	1995
2020 Q1	$10K	Buy	184 +34	+23%	+$2.66K	﹤0.01%	1539
2019 Q4	$10K	Buy	150 +21	+16%	+$2.43K	﹤0.01%	1787
2019 Q3	$24K	Buy	+129	New	+$29.6K	﹤0.01%	1377

Other funds holding FRTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Next Financial Group's FRTX Position: Q4 2021 in Review

Next Financial Group held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q4 2021 at 129 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Next Financial Group first reported a position in FRTX in Q3 2019 and has held it in 9 quarters since. The position peaked at $24K in Q3 2019. 30 funds tracked by Wall St. Rank hold FRTX as of Q4 2021.

Next Financial Group held 129 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $1K as of Q4 2021.
Next Financial Group left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q4 2021.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2827 holding.
Next Financial Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2019 and has held it in 9 quarters since.
Next Financial Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $24K in Q3 2019.
30 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.